These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 15107419)
1. The trimerization domain of NEMO is composed of the interacting C-terminal CC2 and LZ coiled-coil subdomains. Agou F; Traincard F; Vinolo E; Courtois G; Yamaoka S; Israël A; Véron M J Biol Chem; 2004 Jul; 279(27):27861-9. PubMed ID: 15107419 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of NF-kappa B activation by peptides targeting NF-kappa B essential modulator (nemo) oligomerization. Agou F; Courtois G; Chiaravalli J; Baleux F; Coïc YM; Traincard F; Israël A; Véron M J Biol Chem; 2004 Dec; 279(52):54248-57. PubMed ID: 15466857 [TBL] [Abstract][Full Text] [Related]
3. Two-sided ubiquitin binding of NF-κB essential modulator (NEMO) zinc finger unveiled by a mutation associated with anhidrotic ectodermal dysplasia with immunodeficiency syndrome. Ngadjeua F; Chiaravalli J; Traincard F; Raynal B; Fontan E; Agou F J Biol Chem; 2013 Nov; 288(47):33722-33737. PubMed ID: 24100029 [TBL] [Abstract][Full Text] [Related]
4. DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding. Grubisha O; Kaminska M; Duquerroy S; Fontan E; Cordier F; Haouz A; Raynal B; Chiaravalli J; Delepierre M; Israël A; Véron M; Agou F J Mol Biol; 2010 Jan; 395(1):89-104. PubMed ID: 19854204 [TBL] [Abstract][Full Text] [Related]
5. A point mutation in NEMO associated with anhidrotic ectodermal dysplasia with immunodeficiency pathology results in destabilization of the oligomer and reduces lipopolysaccharide- and tumor necrosis factor-mediated NF-kappa B activation. Vinolo E; Sebban H; Chaffotte A; Israël A; Courtois G; Véron M; Agou F J Biol Chem; 2006 Mar; 281(10):6334-48. PubMed ID: 16379012 [TBL] [Abstract][Full Text] [Related]
6. Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO. Chiaravalli J; Fontan E; Fsihi H; Coic YM; Baleux F; Véron M; Agou F Biochem Pharmacol; 2011 Nov; 82(9):1163-74. PubMed ID: 21803029 [TBL] [Abstract][Full Text] [Related]
7. The carboxyl-terminal region of IkappaB kinase gamma (IKKgamma) is required for full IKK activation. Makris C; Roberts JL; Karin M Mol Cell Biol; 2002 Sep; 22(18):6573-81. PubMed ID: 12192055 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO. Wyler E; Kaminska M; Coïc YM; Baleux F; Véron M; Agou F Protein Sci; 2007 Sep; 16(9):2013-22. PubMed ID: 17766391 [TBL] [Abstract][Full Text] [Related]
9. Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysis. Darwech I; Otero J; Alhawagri M; Dai S; Abu-Amer Y J Cell Biochem; 2009 Dec; 108(6):1337-45. PubMed ID: 19830703 [TBL] [Abstract][Full Text] [Related]
10. Structural basis for recognition of diubiquitins by NEMO. Lo YC; Lin SC; Rospigliosi CC; Conze DB; Wu CJ; Ashwell JD; Eliezer D; Wu H Mol Cell; 2009 Mar; 33(5):602-15. PubMed ID: 19185524 [TBL] [Abstract][Full Text] [Related]
11. NEMO trimerizes through its coiled-coil C-terminal domain. Agou F; Ye F; Goffinont S; Courtois G; Yamaoka S; Israël A; Véron M J Biol Chem; 2002 May; 277(20):17464-75. PubMed ID: 11877453 [TBL] [Abstract][Full Text] [Related]
12. Tetrameric oligomerization of IkappaB kinase gamma (IKKgamma) is obligatory for IKK complex activity and NF-kappaB activation. Tegethoff S; Behlke J; Scheidereit C Mol Cell Biol; 2003 Mar; 23(6):2029-41. PubMed ID: 12612076 [TBL] [Abstract][Full Text] [Related]
13. Dimerization of the I kappa B kinase-binding domain of NEMO is required for tumor necrosis factor alpha-induced NF-kappa B activity. Marienfeld RB; Palkowitsch L; Ghosh S Mol Cell Biol; 2006 Dec; 26(24):9209-19. PubMed ID: 17000764 [TBL] [Abstract][Full Text] [Related]
14. Mechanism underlying IκB kinase activation mediated by the linear ubiquitin chain assembly complex. Fujita H; Rahighi S; Akita M; Kato R; Sasaki Y; Wakatsuki S; Iwai K Mol Cell Biol; 2014 Apr; 34(7):1322-35. PubMed ID: 24469399 [TBL] [Abstract][Full Text] [Related]
15. Solution structure of NEMO zinc finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation. Cordier F; Vinolo E; Véron M; Delepierre M; Agou F J Mol Biol; 2008 Apr; 377(5):1419-32. PubMed ID: 18313693 [TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the NEMO ubiquitin-binding domain in complex with Lys 63-linked di-ubiquitin. Yoshikawa A; Sato Y; Yamashita M; Mimura H; Yamagata A; Fukai S FEBS Lett; 2009 Oct; 583(20):3317-22. PubMed ID: 19766637 [TBL] [Abstract][Full Text] [Related]
17. Heptad repeats regulate protein phosphatase 2a recruitment to I-kappaB kinase gamma/NF-kappaB essential modulator and are targeted by human T-lymphotropic virus type 1 tax. Hong S; Wang LC; Gao X; Kuo YL; Liu B; Merling R; Kung HJ; Shih HM; Giam CZ J Biol Chem; 2007 Apr; 282(16):12119-26. PubMed ID: 17314097 [TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. May MJ; D'Acquisto F; Madge LA; Glöckner J; Pober JS; Ghosh S Science; 2000 Sep; 289(5484):1550-4. PubMed ID: 10968790 [TBL] [Abstract][Full Text] [Related]
19. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Yamaoka S; Courtois G; Bessia C; Whiteside ST; Weil R; Agou F; Kirk HE; Kay RJ; Israël A Cell; 1998 Jun; 93(7):1231-40. PubMed ID: 9657155 [TBL] [Abstract][Full Text] [Related]
20. The zinc finger domain of IKKγ (NEMO) protein in health and disease. Shifera AS J Cell Mol Med; 2010 Oct; 14(10):2404-14. PubMed ID: 20345847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]